APPLICATION
NDA016942
TYPE
NDA
ORIGINAL APPROVAL
1971-08-06
LATEST ACTION
1996-04-26
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued
Products
HALOTEXDiscontinued
HALOPROGIN 1% · CREAM · TOPICAL
Approval history
1996-04-26Labeling · Supplement 13AP
1996-04-26Labeling · Supplement 14AP
1986-05-28Labeling · Supplement 17AP
1977-12-22Labeling · Supplement 11AP
1971-08-06Type 1 - New Molecular Entity · Original · priorityAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.